Co-author: Vinit Nair
Co-authored publications (8):
- Garcia C , Cocoros NM , Haynes K et al . Randomized clinical trial using FDA’s Sentinel infrastructure: an analysis assessing feasibility . Podium presented at: 2017 International Society for Pharmacoepidemiology International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 26 - August 30, 2017; Montreal, QC, CA . https://www.sentinelinitiative.org/sites/default/files/Sentinel-ICPE-2017-Presentation-IMPACT-AFib.pdf .
- Kappelman MD , Lewis JD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF-experienced patients with crohn's disease initiating vedolizumab versus ustekinumab .Dig Dis Sci. 2023; 68 (8) : 3413-20 . doi: 10.1007/s10620-023-07942-0 .
- Kappelman MD , Long MD , Zhang X et al . Comparing patient-reported outcomes among anti-TNF experienced patients with ulcerative colitis initiating vedolizumab versus tofacitinib .Crohns Colitis 360. 2023; 5 (3) : otad031 . doi: 10.1093/crocol/otad031 .
- Pokorney SD , Cocoros NM , Al-Khalidi HR et al . Effect of mailing educational material to patients with atrial fibrillation and their clinicians on use of oral anticoagulants: a randomized clinical trial .Jama Netw Open. 2022; 5 (5) : e221432 . doi: 10.1001/jamanetworkopen.2022.14321 .
- Lo Re 3rd V , Carbonari DM , Jacob J et al . Validity of ICD-10-cm diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapies .Pharmacoepidemiol Drug Saf. 2021; 30 (7) : 899-909 . doi: 10.1002/pds.5253 .
- Al-Khatib SM , Pokorney SD , Al-Khalidi HR et al . Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: a population being targeted by the implementation of a randomized controlled trial to improve treatment with oral anticoagulants in patients with atrial fibrillation (impact-afib) .Am Heart J. 2020; 229 : 110-7 . doi: 10.1016/j.ahj.2020.07.012 .
- Garcia C , Haynes K , Pokorney SD et al . Practical challenges in the conduct of pragmatic trials embedded in health plans: lessons of impact-afib, an FDA-CATALYST trial .Clin Trials. 2020; 17 (4) : 360-7 . doi: 10.1177/1740774520928426 .
- Cocoros NM , Pokorney SD , Haynes K et al . Fda-catalyst-using FDA's Sentinel initiative for large-scale pragmatic randomized trials: approach and lessons learned during the planning phase of the first trial .Clin Trials. 2019; 16 (1) : 90-7 . doi: 10.1177/1740774518812776 .